Skip to content

Company information lookup

PROGEN PHARMACEUTICALS LIMITED (PGL)

Discovery, development and commercialisation of small molecule therapeutics primarily for the treatment of cancer.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
PGL 0.180 0% 0.175 0.220 0.180 0.180 0.180 1,600

PROGEN PHARMACEUTICALS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code PGL
Securities
Official Listing Date 22 December, 1995
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.progen-pharma.com
Registered Office Address Level 18, 101 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
Head Office Telephone (07) 3273 9133
Head Office Fax (07) 3375 1168
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
117 VICTORIA STREET, WEST END, QLD, AUSTRALIA, 4101
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Jitto Arulampalam (Executive Chairman, Non Exec. Chairman)
Mr Heng Tang (Managing Director, Executive Director)
Dr Hongjen Chang (Non Exec. Director)
Company Secretary Mr Blair Lucas
Principal Activities Discovery, development and commercialisation of small molecule therapeutics primarily for the treatment of cancer.

PROGEN PHARMACEUTICALS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
07/10/2014   Notice of Annual General Meeting/Proxy Form 22 PDF
29/09/2014   2014 Annual Report 75 PDF
22/09/2014 asterix PG545 Phase 1 Clinical Trial Update 2 PDF
26/08/2014 asterix Preliminary Final Report 57 PDF
29/07/2014 asterix Update to Interim Phase III Results for PI-88 2 PDF
28/07/2014 asterix Interim Phase III Results for PI-88 4 PDF
21/07/2014 asterix EPO to Grant Sulfated Oligosaccharide Derivatives Patent 2 PDF
09/07/2014   Medigen Schedules PI-88 Interim Patient Analysis in July 2 PDF
28/05/2014   Change of Head Office Address 1 PDF
19/05/2014   Change of Director's Interest Notice 3 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
21 Oct 2014 0.180 5.88% 0.210 0.180 11,650
20 Oct 2014 0.170 -2.86% 0.170 0.170 2,500
16 Oct 2014 0.175 2.94% 0.175 0.175 1,262
15 Oct 2014 0.170 0% 0.170 0.170 1,125
14 Oct 2014 0.170 0% 0.170 0.170 20,418

* Volume of shares shown represents only those shares traded on ASX.

PROGEN PHARMACEUTICALS LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security PGL. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security PGL

Warrants & Structured Products

No warrants & Structured Products are available over the security PGL